VR 694
Alternative Names: VR694Latest Information Update: 08 Nov 2010
At a glance
- Originator Vectura
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Bronchitis
Most Recent Events
- 31 May 2007 This programme is still in active development
- 27 Oct 2005 No development reported - Preclinical for Asthma in United Kingdom (Inhalation)
- 27 Oct 2005 No development reported - Preclinical for Bronchitis in United Kingdom (Inhalation)